Jupiter Life Line Hospitals Ltd

Q3 FY26Healthcare Services

Jupiter Life Line Hospitals Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹310

Market cap₹10.4K Cr

P/E54.2

Updated23 Aug 2026

Read5 min read

The short version

Mature hospitals' ARPOB (Average Revenue Per Occupied Bed) expected to grow in line with inflation; newer hospitals may see faster growth initially. New 500-bed Dombivli hospital to start operations in Q1 FY'27, expected EBITDA drag for 1-2 years before turning profitable.

From Jupiter Life Line Hospitals Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Mature hospitals' ARPOB (Average Revenue Per Occupied Bed) expected to grow in line with inflation; newer hospitals may see faster growth initially.
New hospitals like Dombivli expected to take 2-3 years for stabilization; breakeven anticipated by end of year 2 with EBITDA drag initially.
Occupancy growth limited in mature hospitals (e.g., Thane), moderate in Pune, and strong growth opportunity in Indore.
Industry-wide demand-supply mismatch with insufficient high-quality tertiary care supply; growth story expected to continue for multiple decades.
Jupiter plans to expand beyond existing 6 hospitals, committed to Western India, and intends to grow alongside supply.
Insurance renewals are inflation-linked but negotiated annually; uncertain long-term margin impact due to potential wage and cost increases.

2 more points management made on revenue & sales performance

Profitability & Margins

New 500-bed Dombivli hospital to start operations in Q1 FY'27, expected EBITDA drag for 1-2 years before turning profitable.
Indore hospital in growth phase expected to contribute incremental margins over next 2 years.
Mature hospitals (Thane, Pune) expected to have stable margins with limited occupancy growth; capped by finite capacity.
ARPOB (Average Revenue Per Occupied Bed) growth expected to be inflation-linked for mature hospitals; faster growth in early years for new hospitals.
Long-term ARPOB growth uncertain due to inflation, wage trends, trade, taxation; no specific margin guidance provided.
Company plans to add more hospitals (7th hospital under consideration) and grow in line with supply growth over next decade.

2 more points management made on profitability & margins

See what Jupiter Life Line Hospitals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Pune Bibvewadi project: Construction has started, currently at basement work stage; excavation completed. Expected to begin operations in calendar year 2028. Capex incurred so far is around INR 45 crores.
Dombivli hospital: Completed construction of 500-bed hospital at INR 425 crores capex. Launch planned for February 15, 2026, with phased bed activation starting from 200 beds. EBITDA drag expected for ~2 years before profitability.
Mira Road project: Regulatory approvals in progress; construction not yet started; no capex incurred yet.

- Overall capex in 9 months FY '26: INR 425 crores for Dombivli, INR 45 crores for Pune, Mira Road yet to start. - European trade deal and medical equipment imports: Potential future capex savings due to expected reduced import duties, though impact may be dependent on implementation and sourcing from China. The company is committed to growth via greenfield expansions primarily in Western India.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The transcript does not mention any current or future plans for fundraising through debt or equity. Key points related to capex and funding are: - The company is investing in new hospital projects (Dombivli, Pune Bibvewadi, Mira Road) with significant capex already incurred or planned. - Capex for Dombivli is approximately INR 425 crores; Pune has about INR 45 crores spent so far; Mira Road project is in regulatory approval stage.

2 more points management made on fundraising & capital structure

See what Jupiter Life Line Hospitals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention current or expected order book or pending orders for Jupiter Life Line Hospitals Limited. However, relevant information about ongoing and upcoming projects from the call includes: - Dombivli Hospital: Completed construction, 500 beds, INR 425 crores capex, to start operating with 200 beds from Q1 FY27, phased ramp-up planned. - Pune Bibvewadi Project: Construction started (basement work), excavation completed, capex incurred ~INR 45 crores so far, expected commissioning around calendar year 2028. - Mira Road Project: Regulatory approval in process, no construction started yet.

2 more points management made on order book & pipeline

Jupiter Life Line Hospitals Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹388 Cr, net profit ₹50 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Jupiter Life Lin's management said in earlier quarters

Others in Healthcare Services this season

Vijaya Diagnost. (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
Chandan Healthcare Ltd (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
Rainbow Child. (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Jupiter Life Line Hospitals Ltd Q3 FY26 results?

What is Jupiter Life Line Hospitals Ltd share price analysis?

Jupiter Life Line Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 54.1 with a market cap of ₹10,351 Cr. Investors should review the full earnings analysis for detailed insights.

Is Jupiter Life Line Hospitals Ltd planning capital expenditure?

Pune Bibvewadi project: Construction has started, currently at basement work stage; excavation completed.

Keep Jupiter Life Line Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.